Table 2.
Case | Primary | Age (years) | Preoperative Tokuhashi score | pP | PP | AL | PL | MIS | BL | OT | LOS | C | Survival (months) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Lung | 58 | 9 | 2 | 4 | T9 | T7–11 | 2 | 800 | 220 | 5 | Nil | 11 |
2 | MM † | 72 | 8 | 2 | 4 | T12 | T11‐L1 | 1 | 20 | 300 | 30 | Nil | 56* |
3 | Breast | 62 | 7 | 4 | 4 | T8 | T7–9 | 1 | 20 | 120 | 8 | Nil | 3 |
4 | Breast | 46 | 10 | 4 | 4 | T4–6 | T3–7 | 2 | 1000 | 300 | 3 | Nil | 43* |
5 | GIST | 72 | 7 | 0 | 4 | T9 | T8–10 | 1 | 800 | 180 | 14 | Nil | 13 |
6 | RCC | 68 | 13 | 4 | 4 | T6,7 | T5–8 | 3 | 600 | 360 | 10 | Nil | 30 |
7 | HP | 56 | 12 | 0 | 4 | T2–4 | T2–4 | 3 | 1200 | 330 | 20 | Nil | 41 |
8 | RCC | 36 | 12 | 2 | 4 | L3 | T12‐L4 | 3 | 1000 | 330 | 11 | Inf | 28 |
Note: AL, affected level; HP, hemangiopericytoma; Inf, wound infection; MM, multiple myeloma; PL, percutaneous level; PP, post‐ operative power; pP, pre‐operative power; RCC, renal cell carcinoma. *, patient still alive; †, patient did not receive chemotherapy and radiotherapy.